Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 6 studies | 46% ± 13% | |
conventional dendritic cell | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of CCL17 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 97% | 89.02 | 560 / 578 | 70% | 11.39 | 812 / 1155 |
skin | 58% | 27.30 | 1054 / 1809 | 81% | 8.44 | 381 / 472 |
bladder | 52% | 5.95 | 11 / 21 | 67% | 19.16 | 336 / 504 |
thymus | 33% | 16.47 | 215 / 653 | 73% | 21.10 | 442 / 605 |
breast | 46% | 6.59 | 211 / 459 | 59% | 5.55 | 663 / 1118 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.71 | 1 / 1 |
kidney | 53% | 12.04 | 47 / 89 | 47% | 2.87 | 422 / 901 |
tonsil | 0% | 0 | 0 / 0 | 91% | 8.37 | 41 / 45 |
pancreas | 11% | 1.17 | 37 / 328 | 80% | 24.26 | 142 / 178 |
esophagus | 47% | 23.57 | 673 / 1445 | 43% | 2.38 | 78 / 183 |
lymph node | 0% | 0 | 0 / 0 | 83% | 1158.40 | 24 / 29 |
intestine | 37% | 18.12 | 358 / 966 | 36% | 3.12 | 192 / 527 |
uterus | 12% | 1.64 | 21 / 170 | 61% | 6.23 | 280 / 459 |
spleen | 71% | 15.27 | 172 / 241 | 0% | 0 | 0 / 0 |
prostate | 38% | 5.68 | 94 / 245 | 29% | 1.69 | 147 / 502 |
eye | 0% | 0 | 0 / 0 | 68% | 3.04 | 54 / 80 |
stomach | 26% | 5.15 | 92 / 359 | 36% | 1.81 | 104 / 286 |
liver | 32% | 3.81 | 72 / 226 | 23% | 1.42 | 92 / 406 |
brain | 22% | 1.89 | 571 / 2642 | 14% | 1.28 | 101 / 705 |
adipose | 34% | 5.93 | 404 / 1204 | 0% | 0 | 0 / 0 |
ovary | 9% | 1.20 | 16 / 180 | 22% | 1.56 | 93 / 430 |
blood vessel | 23% | 4.44 | 311 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 23% | 52.61 | 213 / 929 | 0% | 0 | 0 / 0 |
heart | 10% | 1.16 | 82 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 7% | 0.39 | 17 / 258 | 3% | 0.19 | 6 / 230 |
muscle | 8% | 0.81 | 62 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0006954 | Biological process | inflammatory response |
GO_0006935 | Biological process | chemotaxis |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0060326 | Biological process | cell chemotaxis |
GO_0007267 | Biological process | cell-cell signaling |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0048020 | Molecular function | CCR chemokine receptor binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0008009 | Molecular function | chemokine activity |
Gene name | CCL17 |
Protein name | C-C motif chemokine 17 (CC chemokine TARC) (Small-inducible cytokine A17) (Thymus and activation-regulated chemokine) |
Synonyms | TARC SCYA17 |
Description | FUNCTION: Chemokine, which displays chemotactic activity for T lymphocytes, preferentially Th2 cells, but not monocytes or granulocytes. Therefore plays an important role in a wide range of inflammatory and immunological processes . Acts by binding to CCR4 at T-cell surface . Mediates GM-CSF/CSF2-driven pain and inflammation . In the brain, required to maintain the typical, highly branched morphology of hippocampal microglia under homeostatic conditions. May be important for the appropriate adaptation of microglial morphology and synaptic plasticity to acute lipopolysaccharide (LPS)-induced neuroinflammation (By similarity). Plays a role in wound healing, mainly by inducing fibroblast migration into the wound (By similarity). . |
Accessions | Q92583 ENST00000219244.9 ENST00000616880.1 |